Update of recent studies in chronic myeloid leukemia

被引:0
|
作者
Karen Seiter
机构
[1] New York Medical College,Division of Hematology and Oncology
关键词
Imatinib; Chronic Myeloid Leukemia; Dasatinib; Nilotinib; Event Free Survival;
D O I
10.1186/1756-8722-2-S1-A2
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Update on emerging treatments for chronic myeloid leukemia
    Fava, Carmen
    Morotti, Alessandro
    Dogliotti, Irene
    Saglio, Giuseppe
    Rege-Cambrin, Giovanna
    EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (02) : 183 - 196
  • [2] Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update
    Eskazan, Ahmet Emre
    Keskin, Dilek
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (09) : 237 - 243
  • [3] Tyrosine kinase inhibitor therapy in chronic myeloid leukemia: update on key adverse events
    Carneiro, Benedito A.
    Kaplan, Jason B.
    Giles, Francis J.
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 457 - 479
  • [4] The role of observational studies in optimizing the clinical management of chronic myeloid leukemia
    Mauro, Michael J.
    Davis, Catherine
    Zyczynski, Teresa
    Khoury, H. Jean
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (01) : 3 - 14
  • [5] Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate
    Zonder J.A.
    Schiffer C.A.
    Current Hematologic Malignancy Reports, 2006, 1 (3) : 141 - 151
  • [6] Chronic myeloid leukemia - update 2020
    Heim, Dominik
    Ebnoether, Monika
    Favre, Genevieve
    THERAPEUTISCHE UMSCHAU, 2019, 76 (09) : 503 - 509
  • [7] Advances in the treatment of chronic myeloid leukemia
    Anna M Eiring
    Jamshid S Khorashad
    Kimberly Morley
    Michael W Deininger
    BMC Medicine, 9
  • [8] Clinical Trials in Chronic Myeloid Leukemia
    Saussele, Susanne
    Pfirrmann, Markus
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (02) : 109 - 115
  • [9] Clinical Trials in Chronic Myeloid Leukemia
    Susanne Saussele
    Markus Pfirrmann
    Current Hematologic Malignancy Reports, 2012, 7 : 109 - 115
  • [10] Treatment options for chronic myeloid leukemia
    Tanaka, Maria Florencia
    Kantarjian, Hagop
    Cortes, Jorge
    Ohanian, Maro
    Jabbour, Elias
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (06) : 815 - 828